<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38088068</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>08</Day></DateCompleted><DateRevised><Year>2024</Year><Month>03</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1778-3585</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Dec</Month><Day>13</Day></PubDate></JournalIssue><Title>European psychiatry : the journal of the Association of European Psychiatrists</Title><ISOAbbreviation>Eur Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Complex association between post-COVID-19 condition and anxiety and depression symptoms.</ArticleTitle><Pagination><StartPage>e1</StartPage><MedlinePgn>e1</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1192/j.eurpsy.2023.2473</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">To assess the associations between anxiety and depressive symptoms and post-COVID-19 condition (PCC) by exploring the direction of these associations and their relevance in the definition of PCC.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Nationwide survey among French adults, recruited between March and April, 2022, using a quota method to capture a representative sample of the general population with regard to sex, age, socioeconomic status, size of the place of residence, and region. We included all participants who met the World Health Organization (WHO) definition of PCC in addition to a random sample of participants infected with SARS-COV-2 for at least 3&#xa0;months but without PCC. Self-reported anxiety and depressive symptoms, chronic anxiety and depression (for more than 3&#xa0;years), and anxiety and depression were measured using the GAD-2 and PHQ-2 questionnaires, respectively.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">In a sample of 1,095 participants with PCC and 1,021 participants infected with SARS-COV-2 without PCC, 21% had self-reported anxiety and 18% self-reported depression, whereas 33% and 20% had current measured symptoms of anxiety and depression, respectively. The high prevalence of these symptoms cannot only be explained by the characterization of PCC, as only 13.4% of anxiety symptoms and 7.6% of depressive symptoms met the WHO criteria for PCC. Only one participant met the WHO criteria based on self-reported anxiety or depressive symptoms alone, as these were always combined with other symptoms in patients with PCC. Chronic symptoms were associated with PCC (aOR 1.27; 95% CI: 1.00-1.61). In addition, measured anxiety was associated with PCC (aOR&#xa0;=&#xa0;1.29; 95% CI: 1.02-1.62).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Pre-COVID-19 chronic anxiety and depression may play a role in the development of PCC or share vulnerability factors with it. Our results challenge the inclusion of anxiety and depression in the definition of PCC.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tebeka</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0269-4600</Identifier><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatry and Neurosciences, Team 1, Universit&#xe9; Paris Cit&#xe9;, INSERM UMR1266, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, AP-HP, Louis Mourier Hospital, Colombes, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carcaillon-Bentata</LastName><ForeName>Laure</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1556-8590</Identifier><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decio</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alleaume</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beltzer</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallay</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemogne</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-3487-4721</Identifier><AffiliationInfo><Affiliation>Center for Research in Epidemiology and Statistics (CRESS), Universit&#xe9; Paris Cit&#xe9; and Universit&#xe9; Sorbonne Paris Nord, Inserm, INRAE, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'Adulte, AP-HP, H&#xf4;pital H&#xf4;tel-Dieu, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pignon</LastName><ForeName>Baptiste</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0003-0526-3136</Identifier><AffiliationInfo><Affiliation>DMU IMPACT, INSERM U955, IMRB, Translational Neuropsychiatry, Fondation FondaMental, Universit&#xe9; Paris-Est-Cr&#xe9;teil (UPEC), AP-HP, H&#xf4;pitaux Universitaires "H. Mondor", Creteil, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Makovski</LastName><ForeName>Tatjana T</ForeName><Initials>TT</Initials><Identifier Source="ORCID">0000-0002-3334-4809</Identifier><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Coste</LastName><ForeName>Jo&#xeb;l</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-7674-7192</Identifier><AffiliationInfo><Affiliation>Department of Non-Communicable Diseases and Injuries, Sant&#xe9; Publique France, The National Public Health Agency, Saint-Maurice, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>12</Month><Day>13</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur Psychiatry</MedlineTA><NlmUniqueID>9111820</NlmUniqueID><ISSNLinking>0924-9338</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003863" MajorTopicYN="N">Depression</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001007" MajorTopicYN="N">Anxiety</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001008" MajorTopicYN="N">Anxiety Disorders</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">general population</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">persistent symptoms</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword></KeywordList><CoiStatement>The authors declare none.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>12</Month><Day>13</Day><Hour>4</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>12</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38088068</ArticleId><ArticleId IdType="pmc">PMC10964277</ArticleId><ArticleId IdType="doi">10.1192/j.eurpsy.2023.2473</ArticleId><ArticleId IdType="pii">S0924933823024732</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Salamanna F, Veronesi F, Martini L, Landini MP, Fini M. Post-COVID-19 syndrome: the persistent symptoms at the post-viral stage of the disease. A systematic review of the current data. Front Med (Lausanne). 2021;8:653516.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8129035</ArticleId><ArticleId IdType="pubmed">34017846</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post COVID-19 condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;16:jiac136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, Shaar BA, Almamlouk R, Riaz M, et al. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau O, Zins M, Touvier M, Wiernik E, Lemogne C, de Lamballerie X, et al. Long-lasting symptoms after an acute COVID-19 infection and factors associated with their resolution. JAMA Netw Open. 2022;5(11):e2240985.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9647489</ArticleId><ArticleId IdType="pubmed">36350653</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV, WHO Clinical Case Definition Working Group on Post-COVID-19 Condition. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022;22(4):e102&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al. Symptoms, complications and management of long COVID: a review. J R Soc Med. 2021;114(9):428&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, Carrat F, Touvier M, Severi G, et al. Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Intern Med. 2022;182(1):1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Santomauro DF, Herrera AMM, Shadid J, Zheng P, Ashbaugh C, Pigott DM, et al. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C, Pan R, Wan X, Tan Y, Xu L, Ho CS, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health. 2020;17(5):E1729.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7084952</ArticleId><ArticleId IdType="pubmed">32155789</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J Med Virol. 2021;93(2):1013&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Paz C, Mascialino G, Adana-D&#xed;az L, Rodr&#xed;guez-Lorenzana A, Simba&#xf1;a-Rivera K, G&#xf3;mez-Barreno L, et al. Anxiety and depression in patients with confirmed and suspected COVID-19 in Ecuador. Psychiatry Clin Neurosci. 2020;74(10):554&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361296</ArticleId><ArticleId IdType="pubmed">32609409</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Lu H, Zeng H, Zhang S, Du Q, Jiang T, et al. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain Behav Immun. 2020;87:49&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7156946</ArticleId><ArticleId IdType="pubmed">32304883</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M, Luciano S, Geddes JR, Harrison PJ. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7(7):611&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S, Kumar V, Chakrabarti S, Hollikatti P, Singh P, Tyagi S, et al. Prevalence and type of functional somatic complaints in patients with first-episode depression. East Asian Arch Psychiatry. 2012;22(4):146&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">23271583</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino E, Ohde S, Rahman M, Takahashi O, Fukui T, Deshpande GA. Variation in somatic symptoms by patient health questionnaire-9 depression scores in a representative Japanese sample. BMC Public Health. 2018;18(1):1406.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6307287</ArticleId><ArticleId IdType="pubmed">30587173</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaracz J, Gattner K, Jaracz K, G&#xf3;rna K. Unexplained painful physical symptoms in patients with major depressive disorder: prevalence. Pathophysiol Manag CNS Drugs. 2016;30(4):293&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4839032</ArticleId><ArticleId IdType="pubmed">27048351</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis GN, Bean DJ. What influences outcomes from inpatient multidisciplinary pain management programs? A systematic review and meta-analysis. Clin J Pain. 2021;37(7):504&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">33883414</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11):e0240784.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S, Quan L, Chavarro JE, Slopen N, Kubzansky LD, Koenen KC, et al. Associations of depression, anxiety, worry, perceived stress, and loneliness prior to infection with risk of post-COVID-19 conditions. JAMA Psychiatry. 2022;79(11):1081&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9453634</ArticleId><ArticleId IdType="pubmed">36069885</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Robineau O, Wiernik E, Carrat F, Severi G, Touvier M, et al. Depression and anxiety before and at the beginning of the COVID-19 pandemic and incident persistent symptoms: a prospective population-based cohort study. Mol Psychiatry. 2023. Jul 19. doi: 10.1038/s41380-023-02179-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-023-02179-9</ArticleId><ArticleId IdType="pubmed">37464077</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne H, Gouraud C, Hulot JS, Blanchard A, Ranque B, Lahlou-Lafor&#xea;t K, et al. Do anxiety and depression predict persistent physical symptoms after a severe COVID-19 episode? A prospective study. Front Psych. 2021;12:757685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8631493</ArticleId><ArticleId IdType="pubmed">34858230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lemogne C, Gouraud C, Pitron V, Ranque B. Why the hypothesis of psychological mechanisms in long COVID is worth considering. J Psychosom Res. 2023;165:111135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9825049</ArticleId><ArticleId IdType="pubmed">36623391</ArticleId></ArticleIdList></Reference><Reference><Citation>Li H, Ge S, Greene B, Dunbar-Jacob J. Depression in the context of chronic diseases in the United States and China. Int J Nurs Sci. 2019;6(1):117&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6608796</ArticleId><ArticleId IdType="pubmed">31406877</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhalal EA, Alhalal IA, Alaida AM, Alhweity SM, Alshojaa AY, Alfaori AT. Effects of chronic pain on sleep quality and depression: a cross-sectional study. Saudi Med J. 2021;42(3):315&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989257</ArticleId><ArticleId IdType="pubmed">33632911</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xfc;fner K, Tymoszuk P, Ausserhofer D, Sahanic S, Pizzini A, Rass V, et al. Who is at risk of poor mental health following coronavirus disease-19 outpatient management? Front Med (Lausanne). 2022;9:792881.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8964263</ArticleId><ArticleId IdType="pubmed">35360744</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouquette A, Descarpentry A, Dione F, Falissard B, Legleye S, Vuillermoz C, et al. Comparison of depression and anxiety following self-reported COVID-19-like symptoms vs SARS-CoV-2 seropositivity in France. JAMA Netw Open. 2023;6(5):e2312892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10176124</ArticleId><ArticleId IdType="pubmed">37166797</ArticleId></ArticleIdList></Reference><Reference><Citation>Plummer F, Manea L, Trepel D, McMillan D. Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis. Gen Hosp Psychiatry. 2016;39:24&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">26719105</ArticleId></ArticleIdList></Reference><Reference><Citation>Staples LG, Dear BF, Gandy M, Fogliati V, Fogliati R, Karin E, et al. Psychometric properties and clinical utility of brief measures of depression, anxiety, and general distress: the PHQ-2, GAD-2, and K-6. Gen Hosp Psychiatry. 2019;56:13&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">30508772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW, Monahan PO, L&#xf6;we B. Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann Intern Med. 2007;146(5):317&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">17339617</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf6;we B, Kroenke K, Gr&#xe4;fe K. Detecting and monitoring depression with a two-item questionnaire (PHQ-2). J Psychosom Res. 2005;58(2):163&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">15820844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kroenke K, Spitzer RL, Williams JBW. The patient health Questionnaire-2: validity of a two-item depression screener. Med Care. 2003;41(11):1284&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">14583691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox B, van Oyen H, Cambois E, Jagger C, le Roy S, Robine JM, et al. The reliability of the minimum European health module. Int J Public Health. 2009;54(2):55&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">19183846</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Heyden J, De Bacquer D, Tafforeau J, Van Herck K. Reliability and validity of a global question on self-reported chronic morbidity. J Public Health. 2014;22(4):371&#x2013;80.</Citation></Reference><Reference><Citation>Berger N, Van Oyen H, Cambois E, Fouweather T, Jagger C, Nusselder W, et al. Assessing the validity of the global activity limitation indicator in fourteen European countries. BMC Med Res Methodol. 2015;15:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4298058</ArticleId><ArticleId IdType="pubmed">25555466</ArticleId></ArticleIdList></Reference><Reference><Citation>Han Q, Zheng B, Daines L, Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens. 2022;11(2):269.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8875269</ArticleId><ArticleId IdType="pubmed">35215212</ArticleId></ArticleIdList></Reference><Reference><Citation>Subramanian A, Nirantharakumar K, Hughes S, Myles P, Williams T, Gokhale KM, et al. Symptoms and risk factors for long COVID in non-hospitalized adults. Nat Med. 2022;1&#x2013;9. doi: 10.1038/s41591-022-01909-w. Epub 2022 Jul 25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01909-w</ArticleId><ArticleId IdType="pmc">PMC9388369</ArticleId><ArticleId IdType="pubmed">35879616</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M, Manoharan L, Elkheir N, Cheng V, Dagens A, Hastie C, et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6(9):e005427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Peghin M, Palese A, Venturini M, De Martino M, Gerussi V, Graziano E, et al. Post-COVID-19 symptoms 6&#xa0;months after acute infection among hospitalized and non-hospitalized patients. Clin Microbiol Infect. 2021;27(10):1507&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8180450</ArticleId><ArticleId IdType="pubmed">34111579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudre CH, Murray B, Varsavsky T, Graham MS, Penfold RS, Bowyer RC, et al. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson KB, Rao M, Bonilla H, Subramanian A, Hack I, Madrigal M, et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73(3):e826&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7929039</ArticleId><ArticleId IdType="pubmed">33624010</ArticleId></ArticleIdList></Reference><Reference><Citation>Baricich A, Borg MB, Cuneo D, Cadario E, Azzolina D, Balbo PE, et al. Midterm functional sequelae and implications in rehabilitation after COVID-19: a cross-sectional study. Eur J Phys Rehabil Med. 2021;57(2):199&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">33565741</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138&#x2013;47.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903920</ArticleId><ArticleId IdType="pubmed">33639239</ArticleId></ArticleIdList></Reference><Reference><Citation>See&#xdf;le J, Waterboer T, Hippchen T, Simon J, Kirchner M, Lim A, et al. Persistent symptoms in adult patients 1 year after coronavirus disease 2019 (COVID-19): a prospective cohort study. Clin Infect Dis. 2022;74(7):1191&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8394862</ArticleId><ArticleId IdType="pubmed">34223884</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu G, Zhen Q, Wang W, Fan S, Wu Q, Zhang C, et al. Health-related quality of life of COVID-19 patients after discharge: a multicenter follow-up study. J Clin Nurs. 2021;30(11&#x2013;12):1742&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8013595</ArticleId><ArticleId IdType="pubmed">33656210</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Cari&#xf1;ena A, Moreno E, Rodr&#xed;guez N, Dom&#xed;nguez MJ, Casal A, et al. Post-COVID-19 functional status six-months after hospitalization. J Infect. 2021;82(4):e31&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. 2021;9(7):747&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, Yao Q, Gu X, Wang Q, Ren L, Wang Y, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Wu D, Yan W, Wang X, Zhang X, Ma K, et al. Twelve-month systemic consequences of coronavirus disease 2019 (COVID-19) in patients discharged from hospital: a prospective cohort study in Wuhan, China. Clin Infect Dis. 2022;74(11):1953&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9187317</ArticleId><ArticleId IdType="pubmed">34390330</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Islam M, Conroy K, Cotler J, Torres C, Johnson M, et al. COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue. 2021;9(2):59&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8411893</ArticleId><ArticleId IdType="pubmed">34484973</ArticleId></ArticleIdList></Reference><Reference><Citation>Latronico N, Peli E, Calza S, Rodella F, Novelli MP, Cella A, et al. Physical, cognitive and mental health outcomes in 1-year survivors of COVID-19-associated ARDS. Thorax. 2022;77(3):300&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">34588274</ArticleId></ArticleIdList></Reference><Reference><Citation>Carcaillon-Bentata L, Makovski TT, Alleaume C, Decio V, Beltzer N, Gallay A, et al. Post-Covid-19 condition: a comprehensive analysis of the World Health Organisation definition. J Infect. 2023;87:e83&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">37604211</ArticleId></ArticleIdList></Reference><Reference><Citation>Ismael F, Bizario JCS, Battagin T, Zaramella B, Leal FE, Torales J, et al. Post-infection depressive, anxiety and post-traumatic stress symptoms: a prospective cohort study in patients with mild COVID-19. Prog Neuro-Psychopharmacol Biol Psychiatry. 2021;111:110341.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8086265</ArticleId><ArticleId IdType="pubmed">33940097</ArticleId></ArticleIdList></Reference><Reference><Citation>Robineau O, Wiernik E, Lemogne C, de Lamballerie X, Ninove L, Blanch&#xe9; H, et al. Persistent symptoms after the first wave of COVID-19 in relation to SARS-CoV-2 serology and experience of acute symptoms: a nested survey in a population-based cohort. Lancet Reg Health Eur. 2022;17:100363.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005155</ArticleId><ArticleId IdType="pubmed">35434687</ArticleId></ArticleIdList></Reference><Reference><Citation>Decio V, Pirard P, Pignon B, Bouaziz O, Perduca V, Chin F, et al. Hospitalization for COVID-19 is associated with a higher risk of subsequent hospitalization for psychiatric disorders: a French nationwide longitudinal study comparing hospitalizations for COVID-19 and for other reasons. Eur Psychiatry. 2022;1&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9677447</ArticleId><ArticleId IdType="pubmed">36266739</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>